(Q43245401)
Statements
Sunitinib in hepatocellular carcinoma: redefining appropriate dosing, schedule, and activity end points (English)
Chantal Dreyer
Eric Raymond
9 November 2009
e248-50; author reply e251-2
scientific article published on 9 November 2009